{"id":"https://openalex.org/W1567719786","doi":"https://doi.org/10.1111/j.1476-5381.2010.01089.x","title":"Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein","display_name":"Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein","alternate_titles":[],"publication_year":2011,"publication_date":"2011-01-12","ids":{"openalex":"https://openalex.org/W1567719786","doi":"https://doi.org/10.1111/j.1476-5381.2010.01089.x","mag":"1567719786","pmid":"https://pubmed.ncbi.nlm.nih.gov/20973777","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3041264"},"language":"en","primary_location":{"id":"doi:10.1111/j.1476-5381.2010.01089.x","doi":"https://doi.org/10.1111/j.1476-5381.2010.01089.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.2010.01089.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.2010.01089.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1567719786"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.2010.01089.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018903821","display_name":"Ju-Hwa Kim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120052","display_name":"National Cancer Center","ror":"https://ror.org/02tsanh21","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I1290491151","https://openalex.org/I2801339556","https://openalex.org/I4210120052"]}],"countries":["KR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ju\u2010Hwa Kim","raw_affiliation_strings":["Research Institute, National Cancer Center, Ilsan-gu, Goyang-si, Gyeonggi-do, South Korea","These authors contributed equally to this work"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Institute, National Cancer Center, Ilsan-gu, Goyang-si, Gyeonggi-do, South Korea","institution_ids":["https://openalex.org/I4210120052"]},{"raw_affiliation_string":"These authors contributed equally to this work","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102879917","display_name":"Min-Ji Chae","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120052","display_name":"National Cancer Center","ror":"https://ror.org/02tsanh21","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I1290491151","https://openalex.org/I2801339556","https://openalex.org/I4210120052"]}],"countries":["KR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Minji Chae","raw_affiliation_strings":["Research Institute, National Cancer Center, Ilsan-gu, Goyang-si, Gyeonggi-do, South Korea","These authors contributed equally to this work"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Institute, National Cancer Center, Ilsan-gu, Goyang-si, Gyeonggi-do, South Korea","institution_ids":["https://openalex.org/I4210120052"]},{"raw_affiliation_string":"These authors contributed equally to this work","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109228861","display_name":"Won Ki Kim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120052","display_name":"National Cancer Center","ror":"https://ror.org/02tsanh21","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I1290491151","https://openalex.org/I2801339556","https://openalex.org/I4210120052"]}],"countries":["KR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Won Ki Kim","raw_affiliation_strings":["Research Institute, National Cancer Center, Ilsan-gu, Goyang-si, Gyeonggi-do, South Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Institute, National Cancer Center, Ilsan-gu, Goyang-si, Gyeonggi-do, South Korea","institution_ids":["https://openalex.org/I4210120052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104387023","display_name":"Youjin Kim","orcid":"https://orcid.org/0009-0000-4430-4100","observed_orcids":["https://orcid.org/0009-0000-4430-4100"]},"institutions":[{"id":"https://openalex.org/I4210120052","display_name":"National Cancer Center","ror":"https://ror.org/02tsanh21","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I1290491151","https://openalex.org/I2801339556","https://openalex.org/I4210120052"]}],"countries":["KR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"You\u2010Jin Kim","raw_affiliation_strings":["Research Institute, National Cancer Center, Ilsan-gu, Goyang-si, Gyeonggi-do, South Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Institute, National Cancer Center, Ilsan-gu, Goyang-si, Gyeonggi-do, South Korea","institution_ids":["https://openalex.org/I4210120052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102785825","display_name":"Han Sung Kang","orcid":"https://orcid.org/0000-0003-2675-0662","observed_orcids":["https://orcid.org/0000-0003-2675-0662"]},"institutions":[{"id":"https://openalex.org/I4210120052","display_name":"National Cancer Center","ror":"https://ror.org/02tsanh21","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I1290491151","https://openalex.org/I2801339556","https://openalex.org/I4210120052"]}],"countries":["KR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Han Sung Kang","raw_affiliation_strings":["Research Institute, National Cancer Center, Ilsan-gu, Goyang-si, Gyeonggi-do, South Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Institute, National Cancer Center, Ilsan-gu, Goyang-si, Gyeonggi-do, South Korea","institution_ids":["https://openalex.org/I4210120052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052433739","display_name":"Hyung Sik Kim","orcid":"https://orcid.org/0000-0001-7657-3970","observed_orcids":["https://orcid.org/0000-0001-7657-3970"]},"institutions":[{"id":"https://openalex.org/I4921948","display_name":"Pusan National University","ror":"https://ror.org/01an57a31","country_code":"KR","type":"education","lineage":["https://openalex.org/I4921948"]}],"countries":["KR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hyung Sik Kim","raw_affiliation_strings":["MRC Center, College of Pharmacy, Pusan National University, Busan, South Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Center, College of Pharmacy, Pusan National University, Busan, South Korea","institution_ids":["https://openalex.org/I4921948"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091003200","display_name":"Sungpil Yoon","orcid":"https://orcid.org/0000-0002-9301-6313","observed_orcids":["https://orcid.org/0000-0002-9301-6313"]},"institutions":[{"id":"https://openalex.org/I4210120052","display_name":"National Cancer Center","ror":"https://ror.org/02tsanh21","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I1290491151","https://openalex.org/I2801339556","https://openalex.org/I4210120052"]}],"countries":["KR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Sungpil Yoon","raw_affiliation_strings":["Research Institute, National Cancer Center, Ilsan-gu, Goyang-si, Gyeonggi-do, South Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Institute, National Cancer Center, Ilsan-gu, Goyang-si, Gyeonggi-do, South Korea","institution_ids":["https://openalex.org/I4210120052"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5091003200"],"corresponding_institution_ids":["https://openalex.org/I4210120052"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":6.0407,"has_fulltext":true,"cited_by_count":146,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.97797553,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":100},"biblio":{"volume":"162","issue":"3","first_page":"773","last_page":"784"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.5156000256538391,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.5156000256538391,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.09449999779462814,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.061400000005960464,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/salinomycin","display_name":"salinomycin","score":1.0},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.984000027179718},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":1.0},{"id":"https://openalex.org/keywords/chemosensitization","display_name":"chemosensitization","score":0.8889999985694885},{"id":"https://openalex.org/keywords/dna-damage","display_name":"DNA damage","score":0.9769999980926514},{"id":"https://openalex.org/keywords/p21","display_name":"p21","score":0.8090000152587891},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8859999775886536},{"id":"https://openalex.org/keywords/p53","display_name":"p53","score":0.878000020980835},{"id":"https://openalex.org/keywords/h2ax","display_name":"H2AX","score":0.8920000195503235},{"id":"https://openalex.org/keywords/brca1","display_name":"BRCA1","score":0.7419999837875366},{"id":"https://openalex.org/keywords/chk1","display_name":"Chk1","score":0.8550000190734863},{"id":"https://openalex.org/keywords/dna-repair-foci","display_name":"DNA repair foci","score":0.7250000238418579},{"id":"https://openalex.org/keywords/proteasome-activity","display_name":"proteasome activity","score":0.9100000262260437},{"id":"https://openalex.org/keywords/cancer-chemotherapy","display_name":"cancer chemotherapy","score":0.5929999947547913}],"concepts":[{"id":"https://openalex.org/C2780358455","wikidata":"https://www.wikidata.org/wiki/Q903780","display_name":"Comet assay","level":4,"score":0.7444308400154114},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.7381676435470581},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.7166066765785217},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.6678622364997864},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.6516556143760681},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.574131965637207},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.5266382694244385},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.5121328830718994},{"id":"https://openalex.org/C88634738","wikidata":"https://www.wikidata.org/wiki/Q24769543","display_name":"Annexin","level":3,"score":0.4780198335647583},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.47673499584198},{"id":"https://openalex.org/C196795494","wikidata":"https://www.wikidata.org/wiki/Q1624817","display_name":"TUNEL assay","level":3,"score":0.46225470304489136},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4461529850959778},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.396962970495224},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3719295859336853},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3694375157356262},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.23537090420722961},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16838273406028748},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.16623833775520325},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000095662","descriptor_name":"Polyether Polyketides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004249","descriptor_name":"DNA Damage","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011714","descriptor_name":"Pyrans","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D012509","descriptor_name":"Sarcoma","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014594","descriptor_name":"Uterine Neoplasms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017304","descriptor_name":"Annexin A5","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020287","descriptor_name":"In Situ Nick-End Labeling","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020552","descriptor_name":"Comet Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D046988","descriptor_name":"Proteasome Endopeptidase Complex","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D050759","descriptor_name":"Cyclin-Dependent Kinase Inhibitor p21","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D056945","descriptor_name":"Hep G2 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1476-5381.2010.01089.x","doi":"https://doi.org/10.1111/j.1476-5381.2010.01089.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.2010.01089.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.2010.01089.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3041264","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3041264/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"},{"id":"pmid:20973777","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20973777","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/j.1476-5381.2010.01089.x","doi":"https://doi.org/10.1111/j.1476-5381.2010.01089.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.2010.01089.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.2010.01089.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1567719786.pdf","grobid_xml":"https://content.openalex.org/works/W1567719786.grobid-xml"},"referenced_works_count":41,"referenced_works":["https://openalex.org/W1840165714","https://openalex.org/W1964597083","https://openalex.org/W1964855516","https://openalex.org/W1986546315","https://openalex.org/W1992708996","https://openalex.org/W1993220341","https://openalex.org/W1995439679","https://openalex.org/W2006999182","https://openalex.org/W2007764368","https://openalex.org/W2024254896","https://openalex.org/W2025314771","https://openalex.org/W2029529047","https://openalex.org/W2029816858","https://openalex.org/W2032743024","https://openalex.org/W2035413197","https://openalex.org/W2035510317","https://openalex.org/W2038961645","https://openalex.org/W2040027552","https://openalex.org/W2043868011","https://openalex.org/W2046024621","https://openalex.org/W2049433896","https://openalex.org/W2049635024","https://openalex.org/W2049820663","https://openalex.org/W2051011734","https://openalex.org/W2058223944","https://openalex.org/W2079148941","https://openalex.org/W2089281483","https://openalex.org/W2092318330","https://openalex.org/W2092967525","https://openalex.org/W2120656656","https://openalex.org/W2123781894","https://openalex.org/W2124443610","https://openalex.org/W2132829295","https://openalex.org/W2146787709","https://openalex.org/W2147967887","https://openalex.org/W2148407509","https://openalex.org/W2152114458","https://openalex.org/W2158302001","https://openalex.org/W2159012899","https://openalex.org/W2161959295","https://openalex.org/W2398614440"],"related_works":["https://openalex.org/W1983933325","https://openalex.org/W2053577452","https://openalex.org/W2025314771","https://openalex.org/W1145969348","https://openalex.org/W2005134848","https://openalex.org/W1992017365","https://openalex.org/W2068048941","https://openalex.org/W2358656823","https://openalex.org/W2338479388","https://openalex.org/W6946273774"],"abstract_inverted_index":{"BACKGROUND":[0],"AND":[1,166],"PURPOSE:":[2],"Salinomycin":[3],"(Sal)":[4],"has":[5],"recently":[6],"been":[7],"shown":[8],"to":[9,24,50,60,75,81,117,173,202,206,233],"inhibit":[10],"various":[11],"cancer":[12,22,115,204,240],"stem":[13],"cells.":[14],"Here,":[15],"we":[16,44,195],"investigated":[17],"whether":[18],"Sal":[19,49,80,86,97,110,140,176,201],"could":[20],"sensitize":[21,203],"cells":[23,116,205],"the":[25,36,46,77,100,112,118,170,188,198,207,234],"effects":[26,120,208],"of":[27,48,79,93,102,114,121,139,147,200,209,236],"doxorubicin":[28],"(DOX)":[29],"or":[30,123,143,155,211,244],"etoposide":[31],"(ETO).":[32],"EXPERIMENTAL":[33],"APPROACH:":[34],"Using":[35],"Comet":[37],"assay,":[38],"immunocytochemistry":[39],"and":[40,72,90,95,107,131,180,221],"Western":[41],"blot":[42],"analysis,":[43],"assessed":[45],"ability":[47,78,199],"increase":[51,82,217],"DNA":[52,88,103,178,219],"breakage.":[53],"We":[54,125],"performed":[55],"a":[56,222],"cell":[57,62],"proliferation":[58],"assay":[59,74],"determine":[61],"viability,":[63],"cellular":[64],"detachment,":[65],"increased":[66,87,111,136,152,162,189],"pre-G1":[67],"region,":[68],"Annexin":[69],"V":[70],"staining":[71],"TUNEL":[73],"measure":[76],"apoptosis.":[83],"KEY":[84],"RESULTS:":[85],"breakage":[89],"phosphorylated":[91],"levels":[92,133],"p53":[94],"H2AX.":[96],"also":[98],"induced":[99],"formation":[101],"foci":[104],"with":[105,141,215],"pH2AX":[106],"53BP1.":[108],"Furthermore,":[109],"sensitivity":[113],"apoptotic":[119],"DOX":[122,142,154,210,243],"ETO.":[124,144],"found":[126],"that":[127,175,197],"pH2AX,":[128],"pBRCA1,":[129],"p53BP1":[130],"pChk1":[132],"were":[134],"greatly":[135],"after":[137],"co-treatment":[138],"The":[145],"level":[146],"anti-apoptotic":[148,225],"p21":[149,227],"protein":[150,226],"was":[151],"by":[153,159,192],"ETO":[156,212,245],"but":[157],"decreased":[158],"Sal,":[160],"which":[161],"proteasome":[163],"activity.":[164],"CONCLUSIONS":[165],"IMPLICATIONS:":[167],"This":[168],"is":[169,213],"first":[171],"study":[172],"report":[174],"increases":[177],"damage,":[179],"this":[181],"effect":[182],"plays":[183],"an":[184,216],"important":[185],"role":[186],"in":[187,218,224],"apoptosis":[190],"caused":[191],"Sal.":[193],"Overall,":[194],"demonstrated":[196],"associated":[214],"damage":[220],"decrease":[223],"levels.":[228],"These":[229],"results":[230],"may":[231],"contribute":[232],"development":[235],"Sal-based":[237],"chemotherapy":[238],"for":[239],"patients":[241],"receiving":[242],"treatment.":[246]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1567719786","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":12},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":12},{"year":2016,"cited_by_count":12},{"year":2015,"cited_by_count":13},{"year":2014,"cited_by_count":14},{"year":2013,"cited_by_count":22},{"year":2012,"cited_by_count":17}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
